|Chemical and physical data|
|Molar mass||310.432 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Viqualine (INN) (developmental code name PK-5078) is an antidepressant and anxiolytic drug that was never marketed. It acts as a potent and selective serotonin releasing agent and serotonin reuptake inhibitor. In addition, viqualine displaces diazepam from the GABAA receptor and produces benzodiazepine-like effects, indicating that it is also a positive allosteric modulator of the benzodiazepine site of the GABAA receptor. The drug has mainly been researched as a potential treatment for alcoholism.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|